To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AFG3L2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
373 supporting clones for gene AFG3L2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB454252.
matches multiple genes
testis .a 1 to 471 1 to 472   tiling clone, also hits gene TUBB6 472/476
(99 %)
4 diff
(99.2 %id)
DN993083 brain, whole brain .a 135 to 831 7 to 702       696/702
(99 %)
9 diff
(98.8 %id)
CV812378 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 173 to 929 1 to 758       758/881
(86 %)
12 diff
(98.7 %id)
NM_006796.2   .a 173 to 3380 1 to 3208 exact RefSeq, AAA   3208/3208
(100 %)
0 diff
(100 %id)
CB994279 placenta, pre-eclamptic placenta .a 197 to 717 27 to 553       527/979
(53 %)
18 diff
(98.2 %id)
CB998005 placenta, pre-eclamptic placenta .a 197 to 775 27 to 604       578/655
(88 %)
12 diff
(98.2 %id)
CB998292 placenta, pre-eclamptic placenta .a 197 to 914 27 to 750       724/854
(84 %)
15 diff
(98.3 %id)
BI088354 cervix .a 198 to 922 1 to 770       628/924
(67 %)
51 diff
(94.5 %id)
AI927088 Kidney .a 203 to 581 385 to 7       379/389
(97 %)
5 diff
(98.8 %id)
BX379544 Placenta Cot 25-normalized .a 204 to 1299 18 to 1109       1092/1147
(95 %)
27 diff
(97.7 %id)
BG818048 anaplastic oligodendroglioma with 1p/19qloss, brain .a 204 to 980 1 to 784       782/784
(99 %)
17 diff
(97.9 %id)
CR981911 T-Lymphocytes .a 213 to 912 1 to 700       700/707
(99 %)
2 diff
(99.8 %id)
CD580287 brain .a 220 to 725 1 to 514       514/957
(53 %)
18 diff
(98.2 %id)
AL539209 brain, fetal brain .a 222 to 1267 1 to 1038       1038/1042
(99 %)
13 diff
(98.8 %id)
BI550738 brain, hippocampus .a 224 to 993 5 to 778       772/778
(99 %)
14 diff
(98.3 %id)
TI_44172244   .a 224 to 993 125 to 898       772/898
(85 %)
14 diff
(98.5 %id)
BM466934 eye, retinoblastoma .a 225 to 717 1 to 499       499/861
(57 %)
13 diff
(98.5 %id)
CR597170 HeLa cells Cot 25-normalized .a 230 to 3181 1 to 2952 exact tiling clone,   2952/2952
(100 %)
0 diff
(100 %id)
AL555390 placenta .a 230 to 1118 1 to 888       888/888
(100 %)
2 diff
(99.8 %id)
BU540651 large cell carcinoma, lung .a 231 to 873 1 to 655       653/1158
(56 %)
23 diff
(98.1 %id)
BI224336 cervical carcinoma cell line, cervix .a 236 to 1101 1 to 878       876/888
(98 %)
23 diff
(97.5 %id)
BQ069891 brain, neuroblastoma, cell line .a 239 to 764 1 to 526       526/1181
(44 %)
12 diff
(99.0 %id)
CT003850 T-Lymphocytes .a 240 to 806 1 to 567       567/572
(99 %)
1 diff
(99.9 %id)
BX402160 Neuroblastoma Cot 25-normalized .a 249 to 1045 1 to 796       523/801
(65 %)
33 diff
(95.9 %id)
BC065016 Eye, retinoblastoma .a 251 to 3208 1 to 2958 exact available from MGC, AAA   2958/2958
(100 %)
2 diff
(100.0 %id)
CN425724 embryonic stem cells, cell lines H1, H7, andH9 .a 251 to 914 1 to 664       664/664
(100 %)
2 diff
(99.7 %id)
BX354702 Neuroblastoma Cot 25-normalized .a 251 to 1279 1 to 1026       1026/1055
(97 %)
17 diff
(98.4 %id)
BU172953 eye, retinoblastoma .a 253 to 1105 1 to 864       864/930
(92 %)
23 diff
(97.6 %id)
Y18314   .a 254 to 3216 1 to 2963 E74G V633A     2963/2963
(100 %)
5 diff
(99.9 %id)
BE889379 leiomyosarcoma, uterus .a 256 to 920 1 to 662       662/866
(76 %)
11 diff
(98.8 %id)
BX448290 fetal liver, Liver .a 258 to 1118 1 to 859       859/1012
(84 %)
10 diff
(99.1 %id)
CX755519 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 263 to 1044 1 to 776     Submitted on the opposite strand 776/825
(94 %)
7 diff
(99.2 %id)
BM473587 melanotic melanoma, skin .a 271 to 1370 1 to 1099       1099/1099
(100 %)
29 diff
(97.4 %id)
BU859081 ovary, teratocarcinoma, cell line .a 275 to 1119 1 to 851       851/882
(96 %)
7 diff
(99.3 %id)
BQ056206 lymph, lymphoma, cell line .a 282 to 1118 1 to 845       845/1020
(82 %)
13 diff
(98.8 %id)
BQ058071 lymph, lymphoma, cell line .a 282 to 921 1 to 645       645/1118
(57 %)
22 diff
(98.1 %id)
BQ062412 lymph, lymphoma, cell line .a 282 to 1005 1 to 726       726/1067
(68 %)
26 diff
(97.6 %id)
BI087974 cervix .a 285 to 1005 1 to 723       721/723
(99 %)
14 diff
(98.1 %id)
BG386745 adenocarcinoma cell line, colon .a 287 to 921 1 to 637       637/947
(67 %)
15 diff
(98.5 %id)
BE906939 epithelioid carcinoma, Pancreas .a 290 to 997 1 to 708       706/878
(80 %)
14 diff
(98.5 %id)
CN425726 embryonic stem cells, cell lines H1, H7, andH9 .a 300 to 707 1 to 408       408/408
(100 %)
0 diff
(100 %id)
CX752854 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 314 to 1009 1 to 693     Submitted on the opposite strand 693/697
(99 %)
6 diff
(99.2 %id)
BG257620 embryonal carcinoma, cell line, testis .a 315 to 991 1 to 674       674/674
(100 %)
6 diff
(99.2 %id)
BI552081 brain, hippocampus .a 341 to 1073 1 to 733       733/733
(100 %)
6 diff
(99.2 %id)
TI_44171707   .a 346 to 1073 89 to 816       728/816
(89 %)
8 diff
(99.1 %id)
CN425723 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 348 to 967 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
BG324604 Kidney, renal cell adenocarcinoma .a 351 to 997 1 to 647       647/856
(75 %)
24 diff
(97.2 %id)
BF310869 brain, neuroblastoma .a 356 to 997 1 to 649       649/924
(70 %)
22 diff
(97.7 %id)
CN482763 eye .a 385 to 829 1 to 445       445/445
(100 %)
1 diff
(99.8 %id)
DN990478 brain, whole brain .a 422 to 1055 1 to 635       633/635
(99 %)
10 diff
(98.5 %id)
BE281004 choriocarcinoma, placenta .a 437 to 920 1 to 483       483/699
(69 %)
15 diff
(97.9 %id)
BQ432215 melanotic melanoma, skin .a 444 to 993 1 to 550       550/922
(59 %)
11 diff
(98.9 %id)
BU158235 eye, retinoblastoma .a 445 to 1204 1 to 774       774/812
(95 %)
21 diff
(97.5 %id)
BG468274 adenocarcinoma cell line, colon .a 483 to 983 1 to 502       502/626
(80 %)
13 diff
(98.0 %id)
TI_154197794   .a 496 to 1390 92 to 977       886/1001
(88 %)
33 diff
(96.8 %id)
TI_154196162   .a 501 to 1394 22 to 911       890/1090
(81 %)
32 diff
(97.1 %id)
BX281738 lymph, lymphoma, cell line .a 516 to 1013 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BM806878 lymph, lymphoma, cell line .a 517 to 1530 1 to 1020       1020/1029
(99 %)
27 diff
(97.4 %id)
CO248794 Chondrosarcoma Lung Metastasis cell lines, lung .a 528 to 1282 1 to 747       747/812
(91 %)
21 diff
(97.5 %id)
CN425730 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 540 to 1154 9 to 625       617/625
(98 %)
8 diff
(98.8 %id)
BQ188437 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 551 to 1082 1 to 532       532/532
(100 %)
0 diff
(100 %id)
TI_151731804   .a 551 to 1093 591 to 49       543/1013
(53 %)
5 diff
(99.6 %id)
BE765046 nervous_tumor .a 580 to 947 1 to 368       368/368
(100 %)
0 diff
(100 %id)
BE765182 nervous_tumor .a 580 to 947 1 to 368       368/368
(100 %)
4 diff
(99.0 %id)
CO247045 Chondrosarcoma Lung Metastasis cell lines, lung .a 629 to 1356 1 to 717       717/815
(87 %)
19 diff
(97.7 %id)
BG472102 eye, retinoblastoma .a 635 to 1297 1 to 668       668/668
(100 %)
14 diff
(98.0 %id)
BG822366 adenocarcinoma cell line, colon .a 635 to 1324 1 to 690       690/690
(100 %)
6 diff
(99.2 %id)
BU844783 ovary, teratocarcinoma, cell line .a 652 to 1525 1 to 885       885/890
(99 %)
13 diff
(98.6 %id)
BU192612 eye, retinoblastoma .a 654 to 1527 1 to 879       879/884
(99 %)
20 diff
(97.8 %id)
BE255424 eye, retinoblastoma .a 655 to 1193 1 to 539       539/540
(99 %)
2 diff
(99.7 %id)
CN425722 embryonic stem cells, DMSO-treated H9 cellline .a 667 to 1404 1 to 738       738/738
(100 %)
0 diff
(100 %id)
BE765165 nervous_tumor .a 728 to 947 1 to 221       221/221
(100 %)
2 diff
(99.1 %id)
BE765195 nervous_tumor .a 728 to 952 246 to 22       225/246
(91 %)
1 diff
(99.6 %id)
BF689935 melanotic melanoma, high MDR (cell line), skin .a 741 to 1393 1 to 649       649/956
(67 %)
12 diff
(98.8 %id)
BG761726 melanotic melanoma, high MDR (cell line), skin .a 741 to 1532 1 to 797       797/843
(94 %)
11 diff
(98.7 %id)
BG763515 melanotic melanoma, high MDR (cell line), skin .a 741 to 1495 1 to 755       755/755
(100 %)
3 diff
(99.7 %id)
BG764556 melanotic melanoma, high MDR (cell line), skin .a 741 to 1531 1 to 790       790/878
(89 %)
26 diff
(97.1 %id)
BG767381 melanotic melanoma, high MDR (cell line), skin .a 741 to 1329 1 to 589       589/589
(100 %)
4 diff
(99.4 %id)
BE796963 lung, small cell carcinoma .a 744 to 1525 1 to 799       799/908
(87 %)
11 diff
(98.8 %id)
BM925574 brain .a 751 to 1678 13 to 944       932/1048
(88 %)
23 diff
(97.9 %id)
CU445711 epidermis .a 812 to 1180 375 to 8     Submitted on the opposite strand 368/388
(94 %)
6 diff
(98.5 %id)
CU449820 epidermis .a 812 to 1180 376 to 8     Submitted on the opposite strand 369/389
(94 %)
6 diff
(98.5 %id)
CU450717 epidermis .a 812 to 1180 376 to 8     Submitted on the opposite strand 369/389
(94 %)
5 diff
(98.8 %id)
TI_154186401   .a 829 to 1582 48 to 798       751/752
(99 %)
4 diff
(99.5 %id)
BF027396 melanotic melanoma, skin .a 830 to 1542 1 to 716       716/729
(98 %)
30 diff
(95.9 %id)
CF125012 Chondrosarcoma Lung Metastasis cell lines, lung .a 831 to 1560 1 to 729       729/729
(100 %)
1 diff
(99.9 %id)
BE389660 endometrium, adenocarcinoma cell line, uterus .a 853 to 1529 1 to 668       668/705
(94 %)
23 diff
(96.8 %id)
BE274203 melanotic melanoma, skin .a 854 to 1516 1 to 657       657/675
(97 %)
19 diff
(97.2 %id)
BE384343 melanotic melanoma, skin .a 854 to 1528 1 to 673       673/674
(99 %)
5 diff
(99.3 %id)
BE409103 choriocarcinoma, placenta .a 854 to 1358 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BE728922 melanotic melanoma, skin .a 854 to 1595 1 to 735       735/735
(100 %)
18 diff
(97.6 %id)
BE885874 leiomyosarcoma, uterus .a 870 to 1581 1 to 708       708/889
(79 %)
12 diff
(98.7 %id)
CX758386 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 878 to 1591 39 to 751     Submitted on the opposite strand 713/751
(94 %)
8 diff
(99.0 %id)
BE835449 prostate_normal .a 906 to 1378 1 to 473       473/473
(100 %)
3 diff
(99.4 %id)
BQ424149 eye, retinoblastoma .a 915 to 1727 1 to 824       822/876
(93 %)
15 diff
(98.3 %id)
BE766106 nervous_tumor .a 919 to 1114 13 to 208       200/208
(96 %)
6 diff
(97.2 %id)
BG386050 adenocarcinoma cell line, colon .a 922 to 1581 12 to 669       656/669
(98 %)
12 diff
(98.3 %id)
BQ950514 sciatic nerve .a 925 to 1523 1 to 601       601/1005
(59 %)
19 diff
(98.2 %id)
BM721869 eye, fetal eye .a 958 to 1468 1 to 512       512/512
(100 %)
2 diff
(99.7 %id)
BX390093   .a 1035 to 1836 21 to 831       811/919
(88 %)
30 diff
(96.8 %id)
BE387511 melanotic melanoma, skin .a 1048 to 1587 1 to 548       548/548
(100 %)
11 diff
(98.0 %id)
BE386023 melanotic melanoma, skin .a 1065 to 1561 1 to 497       497/497
(100 %)
0 diff
(100 %id)
CX873045 embryonic stem .a 1074 to 1867 1 to 794       794/794
(100 %)
5 diff
(99.4 %id)
CB215056 normal endometrium, late proliferativephase, cycle day 13, uterus .a 1078 to 1700 1 to 623       623/624
(99 %)
1 diff
(99.9 %id)
BQ315752 colon .a 1118 to 1603 17 to 499       485/499
(97 %)
17 diff
(96.6 %id)
BE885361 leiomyosarcoma, uterus .a 1119 to 1855 1 to 740       740/882
(83 %)
16 diff
(98.2 %id)
BG339446 leiomyosarcoma cell line, uterus .a 1138 to 1581 1 to 441       441/441
(100 %)
5 diff
(98.9 %id)
BI856039 breast, mammary adenocarcinoma, cell line .a 1173 to 2042 1 to 870       870/871
(99 %)
9 diff
(99.0 %id)
TI_57186520   .a 1173 to 2042 58 to 927       870/871
(99 %)
9 diff
(99.0 %id)
BM459654 leiomyosarcoma, uterus .a 1180 to 1896 1 to 720       720/968
(74 %)
14 diff
(98.6 %id)
BE907535 epithelioid carcinoma, Pancreas .a 1205 to 1831 1 to 629       629/892
(70 %)
11 diff
(98.8 %id)
BE250015 adenocarcinoma cell line, colon .a 1217 to 1561 2 to 347       346/347
(99 %)
9 diff
(97.5 %id)
BE293609 adenocarcinoma cell line, colon .a 1245 to 1561 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
DA531267 brain .a 1261 to 1860 2 to 602   capped   601/601
(100 %)
2 diff
(99.7 %id)
BP296387   .a 1273 to 1852 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
BP205115 coronary artery .a 1275 to 1851 1 to 580       580/580
(100 %)
24 diff
(95.9 %id)
TI_154170146   .a 1281 to 1793 78 to 590       513/521
(98 %)
3 diff
(99.5 %id)
BG386175 adenocarcinoma cell line, colon .a 1312 to 1581 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
BP211170 cerebellum .a 1319 to 1911 1 to 593       593/593
(100 %)
4 diff
(99.4 %id)
BP244179 Liver .a 1323 to 1895 1 to 572       572/572
(100 %)
7 diff
(98.8 %id)
BP244218 Liver .a 1323 to 1890 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
BP282336 bone marrow .a 1333 to 1914 1 to 583       583/583
(100 %)
14 diff
(97.6 %id)
CN425731 embryonic stem cells, DMSO-treated H9 cellline .a 1344 to 1937 1 to 595       595/595
(100 %)
3 diff
(99.5 %id)
AK129504 dermoid tumor .a 1347 to 3208 1 to 1862   available from FLJ,   1862/1862
(100 %)
1 diff
(100.0 %id)
BM754999 stomach .a 1357 to 1845 1 to 491       491/491
(100 %)
3 diff
(99.4 %id)
DA564429 heart .a 1383 to 1911 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
CX870481 embryonic stem .a 1384 to 2164 1 to 781       781/781
(100 %)
2 diff
(99.8 %id)
BI756888 brain .a 1387 to 2174 1 to 806       812/806
(100 %)
40 diff
(95.1 %id)
BE252881 eye, retinoblastoma .a 1393 to 1561 1 to 169       169/169
(100 %)
1 diff
(99.5 %id)
BQ312344 breast_normal .a 1401 to 1723 14 to 334       321/335
(95 %)
9 diff
(97.4 %id)
DR157932 human embryonic stem cells differentiated toan early endodermal cell type .a 1451 to 2082 1 to 631       631/631
(100 %)
3 diff
(99.6 %id)
BX331799 Neuroblastoma Cot 25-normalized .a 1453 to 2495 1 to 1043       1043/1043
(100 %)
12 diff
(98.9 %id)
BG032124 breast, mammary adenocarcinoma, cell line .a 1455 to 2140 1 to 682       682/946
(72 %)
14 diff
(98.6 %id)
BX372090   .a 1463 to 2386 922 to 4       919/922
(99 %)
14 diff
(98.5 %id)
CN425727 embryonic stem cells, DMSO-treated H9 cellline .a 1494 to 2229 1 to 736       736/736
(100 %)
3 diff
(99.6 %id)
DA142323 alzheimer cortex .a 1503 to 2040 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
BG830366 epithelioid carcinoma cell line, Pancreas .a 1515 to 1581 1 to 67       67/67
(100 %)
1 diff
(98.6 %id)
BU540721 epithelioid carcinoma cell line, Pancreas .a 1540 to 2352 45 to 863       819/889
(92 %)
34 diff
(96.2 %id)
AW248384 lung, small cell carcinoma .a 1555 to 2067 1 to 513       513/513
(100 %)
7 diff
(98.7 %id)
BG029369 Bone, osteosarcoma, cell line .a 1561 to 2236 18 to 693       678/829
(81 %)
27 diff
(96.8 %id)
CR987348 T-Lymphocytes .a 1615 to 2439 1 to 825       825/825
(100 %)
2 diff
(99.8 %id)
BG389667 embryonal carcinoma, cell line, testis .a 1622 to 2258 1 to 636       636/636
(100 %)
2 diff
(99.7 %id)
BM551355 duodenal adenocarcinoma, cell line, small intestine .a 1649 to 2542 1 to 902       902/1126
(80 %)
34 diff
(97.0 %id)
DA607828   .a 1666 to 2283 2 to 619   capped   618/618
(100 %)
2 diff
(99.7 %id)
BM476472 lymph, lymphoma, cell line .a 1685 to 2540 1 to 858       858/1062
(80 %)
16 diff
(98.5 %id)
BP257436 heart .a 1690 to 2269 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BE173806 head_neck .a 1692 to 1885 30 to 230       201/233
(86 %)
15 diff
(93.6 %id)
DA142086 alzheimer cortex .a 1692 to 2250 2 to 560   capped   559/559
(100 %)
4 diff
(99.3 %id)
BG877765 head_neck .a 1696 to 2166 9 to 477       469/483
(97 %)
10 diff
(98.0 %id)
BP262232 small intestine .a 1696 to 2278 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
AL558924 T cells from T cell leukemia .a 1719 to 2572 1 to 854   fully sequenced,   854/854
(100 %)
2 diff
(99.8 %id)
D16987   .a 1725 to 1785 1 to 61       61/61
(100 %)
0 diff
(100 %id)
CN425720 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1733 to 2029 12 to 308       297/308
(96 %)
8 diff
(97.5 %id)
BE746208 adenocarcinoma cell line, ovary .a 1735 to 2321 1 to 589       591/609
(97 %)
17 diff
(97.3 %id)
BU945315 mixed (pool of 40 RNAs) .a 1747 to 2582 1 to 835       835/835
(100 %)
12 diff
(98.6 %id)
AA317050 lung .a 1756 to 2076 1 to 322       322/322
(100 %)
4 diff
(98.8 %id)
BP417315 small intestine .a 1765 to 2330 1 to 566     Submitted on the opposite strand 566/566
(100 %)
2 diff
(99.7 %id)
BP375438 uterus .a 1807 to 2390 1 to 582       582/582
(100 %)
13 diff
(97.8 %id)
BU179392 melanotic melanoma, cell line, skin .a 1811 to 2688 1 to 880       880/889
(98 %)
7 diff
(99.3 %id)
BQ878033 melanotic melanoma, cell line, skin .a 1811 to 2714 1 to 909       909/909
(100 %)
13 diff
(98.6 %id)
BU166687 melanotic melanoma, cell line, skin .a 1811 to 2703 1 to 901       901/907
(99 %)
18 diff
(98.1 %id)
BQ684490 melanotic melanoma, cell line, skin .a 1811 to 2542 1 to 737       737/946
(77 %)
12 diff
(98.8 %id)
BQ677524 melanotic melanoma, cell line, skin .a 1811 to 2536 1 to 730       730/910
(80 %)
24 diff
(97.4 %id)
BQ680751 melanotic melanoma, cell line, skin .a 1811 to 2750 1 to 944       944/945
(99 %)
18 diff
(98.1 %id)
BU157848 melanotic melanoma, cell line, skin .a 1811 to 2543 1 to 737       737/954
(77 %)
7 diff
(99.3 %id)
BQ680502 melanotic melanoma, cell line, skin .a 1811 to 2543 1 to 737       737/951
(77 %)
7 diff
(99.3 %id)
BX426380 B cells (Ramos cell line) .a 1819 to 2635 1 to 817   fully sequenced,   817/817
(100 %)
3 diff
(99.7 %id)
BE391498 endometrium, adenocarcinoma cell line, uterus .a 1825 to 2312 1 to 490       490/490
(100 %)
6 diff
(98.8 %id)
BE747253 adenocarcinoma cell line, ovary .a 1836 to 2629 1 to 790       790/1117
(70 %)
13 diff
(98.9 %id)
CN425728 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1843 to 2607 1 to 764       764/764
(100 %)
7 diff
(99.1 %id)
BG474275 eye, retinoblastoma .a 1845 to 2462 1 to 618       618/619
(99 %)
12 diff
(98.1 %id)
AV683967 hepatocellular carcinoma .a 1852 to 2491 1 to 634       634/635
(99 %)
9 diff
(98.6 %id)
CD105502 brain, Pituitary .a 1853 to 2716 1 to 868       868/872
(99 %)
9 diff
(99.0 %id)
BM011034 brain, neuroblastoma, cell line .a 1863 to 2638 1 to 781       781/783
(99 %)
11 diff
(98.6 %id)
TI_59379925   .a 1864 to 2638 105 to 884       780/782
(99 %)
10 diff
(98.8 %id)
BE799441 lung, small cell carcinoma .a 1876 to 2395 39 to 556       518/561
(92 %)
16 diff
(97.2 %id)
BM013493 breast, mammary adenocarcinoma, cell line .a 1898 to 2606 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
TI_59391389   .a 1898 to 2606 94 to 802       709/709
(100 %)
4 diff
(99.5 %id)
BQ635933 eye, retina .a 1907 to 2516 1 to 610       610/610
(100 %)
0 diff
(100 %id)
CX751946 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1919 to 2658 1 to 740     Submitted on the opposite strand 740/740
(100 %)
1 diff
(99.9 %id)
CN425721 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1920 to 2533 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
CN425719 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1943 to 2256 1 to 314       314/314
(100 %)
0 diff
(100 %id)
BM042033 melanotic melanoma, cell line, skin .a 1974 to 2572 1 to 600   fully sequenced,   600/600
(100 %)
4 diff
(99.4 %id)
BU185508 melanotic melanoma, cell line, skin .a 1974 to 2649 20 to 696       677/975
(69 %)
16 diff
(98.4 %id)
BQ888719 melanotic melanoma, cell line, skin .a 1976 to 2779 1 to 810       810/936
(86 %)
12 diff
(98.8 %id)
BQ679935 melanotic melanoma, cell line, skin .a 1976 to 2917 1 to 960       960/961
(99 %)
35 diff
(96.4 %id)
BQ680400 melanotic melanoma, cell line, skin .a 1976 to 2788 1 to 820       820/954
(85 %)
14 diff
(98.6 %id)
BF317134 brain, neuroblastoma .a 1989 to 2672 1 to 680       680/681
(99 %)
21 diff
(97.0 %id)
BI092670 cervix .a 1992 to 2830 1 to 838       840/846
(99 %)
15 diff
(98.3 %id)
BE867844 adenocarcinoma, colon .a 1994 to 2675 1 to 671       675/757
(89 %)
14 diff
(98.2 %id)
AA379034 synovial membrane .a 1998 to 2352 1 to 359       359/374
(95 %)
10 diff
(97.4 %id)
BG743289 skin .a 1998 to 2793 1 to 797       797/797
(100 %)
2 diff
(99.8 %id)
BM762949 myeloma .a 2006 to 2606 1 to 601       601/601
(100 %)
2 diff
(99.7 %id)
BM798784 myeloma .a 2006 to 2378 1 to 373       373/373
(100 %)
2 diff
(99.5 %id)
CF454631 peripheral nervous system .a 2020 to 2785 33 to 795       763/798
(95 %)
5 diff
(99.4 %id)
CD579646 brain .a 2027 to 2691 1 to 669       669/680
(98 %)
7 diff
(99.0 %id)
CV368516 lung_tumor .a 2030 to 2442 36 to 449       414/449
(92 %)
7 diff
(98.5 %id)
BP381486 adipose tissue .a 2037 to 2653 1 to 618       618/618
(100 %)
21 diff
(96.7 %id)
BF036766 adenocarcinoma, ovary .a 2050 to 2699 1 to 649       649/649
(100 %)
4 diff
(99.4 %id)
EB388025 eye, optic nerve .a 2075 to 2714 1 to 641       641/641
(100 %)
42 diff
(93.5 %id)
BQ053131 blood, natural killer cells, cell line .a 2077 to 3061 1 to 991       991/1052
(94 %)
21 diff
(98.1 %id)
BM699661 eye, lens .a 2077 to 2631 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BU945199 mixed (pool of 40 RNAs) .a 2105 to 2948 1 to 848       848/850
(99 %)
32 diff
(96.3 %id)
BF672624 muscle (skeletal) .a 2116 to 2800 1 to 676       676/860
(78 %)
21 diff
(97.6 %id)
BU184233 eye, retinoblastoma .a 2152 to 2967 1 to 823       823/888
(92 %)
20 diff
(97.8 %id)
BM541550 leiomyosarcoma, uterus .a 2160 to 3207 1 to 1048       1048/1066
(98 %)
34 diff
(96.9 %id)
BQ948787 eye, normal pigmented retinal epithelium .a 2161 to 3023 1 to 875       875/916
(95 %)
16 diff
(98.3 %id)
CV573985 cornea, eye .a 2168 to 2774 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BG696429 skin .a 2171 to 2970 1 to 803       803/803
(100 %)
13 diff
(98.4 %id)
BM051423 eye, normal pigmented retinal epithelium .a 2182 to 3050 1 to 884       884/888
(99 %)
32 diff
(96.4 %id)
CA454757   .a 2197 to 2886 37 to 723       687/1050
(65 %)
13 diff
(98.8 %id)
CB159770 Liver .a 2210 to 2733 1 to 524       524/524
(100 %)
0 diff
(100 %id)
FN120146 breast carcinoma .a 2214 to 2297 1 to 84       84/84
(100 %)
2 diff
(97.7 %id)
BE871337 adenocarcinoma, colon .a 2214 to 3006 17 to 802       788/913
(86 %)
42 diff
(95.4 %id)
BM474953 duodenal adenocarcinoma, cell line, small intestine .a 2217 to 2798 1 to 592       592/1097
(53 %)
21 diff
(98.1 %id)
CN425732 embryonic stem cells, cell lines H1, H7, andH9 .a 2247 to 2916 1 to 670       670/670
(100 %)
1 diff
(99.9 %id)
AL577906 placenta .a 2248 to 3181 933 to 1       933/933
(100 %)
13 diff
(98.7 %id)
BQ679484 melanotic melanoma, cell line, skin .a 2257 to 3196 16 to 964       949/964
(98 %)
43 diff
(95.6 %id)
BQ889003 melanotic melanoma, cell line, skin .a 2259 to 3023 1 to 768       768/891
(86 %)
7 diff
(99.3 %id)
BU167971 melanotic melanoma, cell line, skin .a 2259 to 3049 1 to 799       799/882
(90 %)
13 diff
(98.6 %id)
BU179626 melanotic melanoma, cell line, skin .a 2259 to 3049 1 to 800       800/938
(85 %)
13 diff
(98.7 %id)
BU839293 melanotic melanoma, cell line, skin .a 2259 to 3031 1 to 782       782/936
(83 %)
14 diff
(98.6 %id)
BU185862 melanotic melanoma, cell line, skin .a 2271 to 3098 5 to 852       848/975
(86 %)
43 diff
(95.6 %id)
BG109956 Bone, osteosarcoma, cell line .a 2289 to 3014 1 to 727       727/729
(99 %)
3 diff
(99.6 %id)
BM475634 embryonal carcinoma, cell line, testis .a 2291 to 3205 16 to 937       922/1009
(91 %)
18 diff
(98.3 %id)
BG682951 brain, neuroblastoma, cell line .a 2302 to 2644 1 to 343   fully sequenced,   343/343
(100 %)
1 diff
(99.8 %id)
AW246169 lung, small cell carcinoma .a 2305 to 2745 31 to 472       442/472
(93 %)
14 diff
(97.1 %id)
AA115675 colon, tumor .a 2324 to 2762 1 to 441   fully sequenced,   441/441
(100 %)
2 diff
(99.6 %id)
BE264819 lung, small cell carcinoma .a 2324 to 2732 1 to 409       409/411
(99 %)
1 diff
(99.8 %id)
CN425725 embryonic stem cells, cell lines H1, H7, andH9 .a 2332 to 2995 1 to 664       664/664
(100 %)
1 diff
(99.9 %id)
BE816069 breast_normal .a 2344 to 2805 13 to 474       463/475
(97 %)
9 diff
(98.2 %id)
BE816071 breast_normal .a 2344 to 2804 13 to 473       462/473
(97 %)
7 diff
(98.6 %id)
BX329397 Neuroblastoma Cot 25-normalized .a 2344 to 3202 869 to 4       866/869
(99 %)
25 diff
(97.2 %id)
AL567732 brain, fetal brain .a 2344 to 3341 997 to 1       997/1078
(92 %)
13 diff
(98.8 %id)
BX354701 Neuroblastoma Cot 25-normalized .a 2349 to 3333 983 to 1       983/991
(99 %)
5 diff
(99.5 %id)
BX379543 Placenta Cot 25-normalized .a 2351 to 3321 993 to 30       964/999
(96 %)
10 diff
(99.0 %id)
BX448289 fetal liver, Liver .a 2351 to 3350 992 to 1       992/998
(99 %)
22 diff
(97.8 %id)
TI_151770420   .a 2355 to 3088 106 to 848       743/1015
(73 %)
25 diff
(97.6 %id)
FN057602 breast carcinoma .a 2357 to 2450 1 to 93       93/93
(100 %)
4 diff
(95.7 %id)
CN425733 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2368 to 3105 9 to 746       738/746
(98 %)
6 diff
(99.2 %id)
TI_227714250   .a 2382 to 3358 1057 to 87   AAA   971/1010
(96 %)
21 diff
(98.0 %id)
BG033293 breast, mammary adenocarcinoma, cell line .a 2398 to 3143 1 to 746       746/956
(78 %)
21 diff
(97.9 %id)
BG573551 placenta .a 2399 to 2998 1 to 601       601/604
(99 %)
2 diff
(99.7 %id)
BG697831 skin .a 2421 to 3218 1 to 796       796/851
(93 %)
11 diff
(98.8 %id)
BI521404 pooled pancreas and spleen .a 2429 to 2572 1 to 145   fully sequenced,   145/145
(100 %)
7 diff
(95.2 %id)
BX447640 B cells (Ramos cell line) .a 2441 to 3163 738 to 1       738/740
(99 %)
37 diff
(95.0 %id)
BU941452 mixed (pool of 40 RNAs) .a 2461 to 3250 1 to 804       804/804
(100 %)
23 diff
(97.2 %id)
DB019720 testis .a 2476 to 3050 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
Z28642 leg muscle, skeletal muscle .a 2478 to 2714 1 to 237       237/237
(100 %)
5 diff
(97.9 %id)
AA164648   .a 2483 to 2959 1 to 483       483/494
(97 %)
12 diff
(97.6 %id)
AA598437 lung, lung carcinoma .a 2483 to 2993 1 to 510     Submitted on the opposite strand 510/510
(100 %)
3 diff
(99.5 %id)
BI522231 pooled pancreas and spleen .a 2511 to 3305 816 to 20   fully sequenced,   797/816
(97 %)
0 diff
(100 %id)
BM042677 melanotic melanoma, cell line, skin .a 2511 to 3180 675 to 2   fully sequenced,   674/675
(99 %)
1 diff
(99.9 %id)
AL580634 T cells from T cell leukemia .a 2512 to 3330 822 to 1   fully sequenced,   822/822
(100 %)
1 diff
(99.9 %id)
BE293402 adenocarcinoma cell line, colon .a 2540 to 3306 775 to 8       768/849
(90 %)
0 diff
(100 %id)
BF690162 melanotic melanoma, high MDR (cell line), skin .a 2540 to 3173 698 to 33       666/1001
(66 %)
69 diff
(93.2 %id)
AA362682   .a 2542 to 2685 1 to 145       145/150
(96 %)
1 diff
(99.4 %id)
CA453608 mixed (pool of 40 RNAs) .a 2554 to 3205 1 to 656       656/731
(89 %)
6 diff
(99.2 %id)
EC511543 Prostate .a 2563 to 2654 1 to 91       91/103
(88 %)
2 diff
(98.1 %id)
BP381808 adipose tissue .a 2575 to 3190 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BE892190 melanotic melanoma, skin .a 2580 to 3306 1 to 730   AAA   730/788
(92 %)
10 diff
(98.8 %id)
BX331798 Neuroblastoma Cot 25-normalized .a 2597 to 3159 562 to 1       562/563
(99 %)
24 diff
(95.8 %id)
CK301097 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2602 to 3208 625 to 19   AAA   607/614
(98 %)
0 diff
(100 %id)
TI_151808700   .a 2602 to 3208 75 to 680   fully sequenced, AAA   606/606
(100 %)
1 diff
(99.9 %id)
BX426379 B cells (Ramos cell line) .a 2605 to 3171 567 to 1   fully sequenced,   567/567
(100 %)
24 diff
(95.8 %id)
BG683669 brain, neuroblastoma, cell line .a 2614 to 3319 721 to 12   fully sequenced,   710/721
(98 %)
6 diff
(99.2 %id)
BP275233 Kidney .a 2622 to 3202 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BU197242 epidermoid carcinoma, cell line, salivary gland .a 2624 to 3172 9 to 557       549/1172
(46 %)
6 diff
(99.5 %id)
C05256 heart .a 2626 to 2975 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AW197062 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 2626 to 3206 581 to 1       581/581
(100 %)
4 diff
(99.4 %id)
TI_154101407   .a 2634 to 3366 805 to 82   AAA   724/788
(91 %)
14 diff
(98.3 %id)
CA432066 cell lines, Enchondroma .a 2646 to 3380 756 to 19   AAA   738/738
(100 %)
7 diff
(99.1 %id)
CB529389 Aveolar Macrophage, lung .a 2646 to 3375 748 to 19   AAA   730/730
(100 %)
1 diff
(99.9 %id)
TI_151732291   .a 2647 to 3208 642 to 81   fully sequenced, AAA   562/562
(100 %)
0 diff
(100 %id)
CD364963 Alveolar Macrophage, lung .a 2676 to 3358 701 to 19   AAA   683/683
(100 %)
1 diff
(99.9 %id)
BM755958 Ascites, stomach .a 2687 to 3099 1 to 413       413/413
(100 %)
2 diff
(99.6 %id)
TI_154123722   .a 2689 to 3375 770 to 90   AAA   681/902
(75 %)
30 diff
(96.7 %id)
AW771356 colon, juvenile granulosa tumor .a 2696 to 3210 516 to 2       515/516
(99 %)
0 diff
(100 %id)
CB528874 Aveolar Macrophage, lung .a 2696 to 3375 698 to 19   AAA   680/680
(100 %)
0 diff
(100 %id)
AA593794 breast, breast tumor .a 2698 to 3212 516 to 2       515/516
(99 %)
0 diff
(100 %id)
CB529084 Aveolar Macrophage, lung .a 2702 to 3366 682 to 19   AAA   664/664
(100 %)
1 diff
(99.9 %id)
CA441873 Chondrosarcoma, Left Pubic Bone .a 2703 to 3366 683 to 19   AAA   665/666
(99 %)
4 diff
(99.4 %id)
BQ447923 Knee, Osteoarthritic Cartilage .a 2703 to 3380 693 to 17   AAA   677/677
(100 %)
1 diff
(99.9 %id)
BU737481 eye, lens .a 2727 to 3366 658 to 19   AAA   640/640
(100 %)
1 diff
(99.9 %id)
AA115676 colon, tumor .a 2742 to 3208 469 to 1   fully sequenced,   469/469
(100 %)
5 diff
(99.0 %id)
BU732565 eye, optic nerve .a 2761 to 3380 638 to 19   AAA   620/620
(100 %)
5 diff
(99.2 %id)
AI613176 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2777 to 3216 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI872432 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2778 to 3209 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
BE293797 adenocarcinoma cell line, colon .a 2800 to 3303 509 to 3       507/509
(99 %)
0 diff
(100 %id)
AA715131 normal prostate, Prostate .a 2802 to 3210 411 to 5       407/411
(99 %)
0 diff
(100 %id)
AW874279 tumor, uterus .a 2803 to 3210 408 to 1       408/408
(100 %)
0 diff
(100 %id)
BF794329 lymph, lymphoma, cell line .a 2822 to 3211 1 to 390   AAA   390/390
(100 %)
0 diff
(100 %id)
BX091241 breast .a 2825 to 3380 1 to 556   AAA   556/556
(100 %)
0 diff
(100 %id)
R74139 breast .a 2825 to 3175 1 to 352   fully sequenced,   352/352
(100 %)
3 diff
(99.2 %id)
H51883 breast .a 2825 to 3256 1 to 447       447/456
(98 %)
21 diff
(95.4 %id)
BM993361 lung, Metastatic Chondrosarcoma .a 2828 to 3366 557 to 19   AAA   539/539
(100 %)
1 diff
(99.9 %id)
BG570900 placenta .a 2841 to 3196 1 to 360       360/860
(41 %)
5 diff
(99.5 %id)
BU740056 eye, fetal eye .a 2864 to 3365 528 to 27       502/528
(95 %)
0 diff
(100 %id)
F23481 pectoral muscle (after mastectomy) .a 2865 to 3045 1 to 183       183/184
(99 %)
12 diff
(93.5 %id)
BF174402 blood .a 2866 to 3192 1 to 317       317/317
(100 %)
10 diff
(96.9 %id)
AA598847   .a 2869 to 3208 340 to 1       340/340
(100 %)
0 diff
(100 %id)
AI608796 normal gingiva (cell line from immortalizedkeratinocytes) .a 2870 to 3375 523 to 18   AAA   506/506
(100 %)
4 diff
(99.3 %id)
AW081656 colon, moderately differentiated adenocarcinoma .a 2876 to 3381 508 to 3   tiling clone,   506/508
(99 %)
0 diff
(100 %id)
BM840267 lymph node, stomach .a 2876 to 3375 1 to 500   AAA   500/500
(100 %)
0 diff
(100 %id)
BM842089 lymph node, stomach .a 2876 to 3376 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BE873992 large cell carcinoma, undifferentiated, lung .a 2883 to 3363 1 to 495       495/542
(91 %)
22 diff
(96.0 %id)
AW317076 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2905 to 3379 477 to 3       475/477
(99 %)
0 diff
(100 %id)
AA284732 ovarian tumor, ovary .a 2927 to 3157 1 to 227   fully sequenced,   227/227
(100 %)
5 diff
(97.8 %id)
BF222624 Prostate .a 2929 to 3366 439 to 1       439/439
(100 %)
1 diff
(99.8 %id)
AW249897 lung, small cell carcinoma .a 2932 to 3375 454 to 11   AAA   444/444
(100 %)
4 diff
(99.1 %id)
BU589219 mixed (pool of 40 RNAs) .a 2949 to 3365 1 to 417       417/934
(44 %)
4 diff
(99.6 %id)
AA551931 colon, tumor .a 2952 to 3366 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI571510 adenocarcinoma, Pancreas .a 2956 to 3366 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AI623518 adenocarcinoma, Pancreas .a 2956 to 3379 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AI827658 pooled .a 2956 to 3334 424 to 46       379/424
(89 %)
0 diff
(100 %id)
AW080550 colon, moderately differentiated adenocarcinoma .a 2956 to 3381 431 to 7       425/431
(98 %)
0 diff
(100 %id)
AI983179 adenocarcinoma, Pancreas .a 2958 to 3381 425 to 1       425/425
(100 %)
2 diff
(99.6 %id)
AI891039 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2961 to 3381 429 to 9       421/429
(98 %)
0 diff
(100 %id)
AA384711 thyroid gland .a 2962 to 3238 1 to 278       278/279
(99 %)
2 diff
(99.3 %id)
N22955 nose, olfactory epithelium .a 2966 to 3377 413 to 2       412/414
(99 %)
0 diff
(100 %id)
AI889665 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2966 to 3380 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AW044550 pooled .a 2973 to 3208 236 to 1       236/236
(100 %)
0 diff
(100 %id)
AW150357 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2979 to 3375 407 to 11   AAA   397/397
(100 %)
1 diff
(99.8 %id)
AA740332 2 pooled tumors (clear cell type), Kidney .a 2983 to 3383 405 to 5   tiling clone,   401/405
(99 %)
0 diff
(100 %id)
CB051481 Prostate .a 2984 to 3347 364 to 1       364/365
(99 %)
5 diff
(98.7 %id)
AI865641 normal prostate, Prostate .a 2985 to 3380 396 to 1       396/397
(99 %)
0 diff
(100 %id)
AI261456 Kidney .a 2986 to 3367 384 to 3       382/384
(99 %)
0 diff
(100 %id)
AI357877 Kidney, renal cell tumor .a 2986 to 3380 422 to 28   AAA   395/395
(100 %)
4 diff
(99.0 %id)
AI540573 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2986 to 3367 383 to 2       382/383
(99 %)
0 diff
(100 %id)
AA164649   .a 2992 to 3367 379 to 1       379/432
(87 %)
3 diff
(99.4 %id)
AI299188 carcinoid, lung .a 2993 to 3375 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AI302753 carcinoid, lung .a 2994 to 3367 377 to 4       374/377
(99 %)
0 diff
(100 %id)
AA905788 pooled .a 2995 to 3381 387 to 1       387/543
(71 %)
6 diff
(98.9 %id)
W56571 heart .a 3003 to 3361 1 to 358   fully sequenced,   358/358
(100 %)
4 diff
(98.9 %id)
AA167325   .a 3031 to 3210 180 to 1       180/181
(99 %)
0 diff
(100 %id)
AI289601 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3032 to 3380 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AW247946 lung, small cell carcinoma .a 3057 to 3380 337 to 11   AAA   327/327
(100 %)
3 diff
(99.1 %id)
AW263836 lung, two pooled squamous cell carcinomas .a 3067 to 3380 315 to 1       315/315
(100 %)
5 diff
(98.5 %id)
BM845638 lymph node, stomach .a 3074 to 3296 1 to 223       223/223
(100 %)
4 diff
(98.3 %id)
EC579301 Prostate .a 3079 to 3172 1 to 94       94/94
(100 %)
2 diff
(97.9 %id)
EC520976 Prostate .a 3080 to 3172 1 to 92       92/92
(100 %)
1 diff
(99.0 %id)
EC520105 Prostate .a 3081 to 3172 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
W56804 heart .a 3081 to 3378 298 to 1   fully sequenced,   298/298
(100 %)
0 diff
(100 %id)
AA995468 germ cell tumor .a 3087 to 3367 282 to 2       281/282
(99 %)
0 diff
(100 %id)
AI538415 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3106 to 3358 273 to 21   AAA   253/253
(100 %)
0 diff
(100 %id)
AA287152 ovarian tumor, ovary .a 3127 to 3366 239 to 1   fully sequenced,   239/239
(100 %)
0 diff
(100 %id)
EC526125 Prostate .a 3140 to 3247 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
R74045 breast .a 3145 to 3380 248 to 1   fully sequenced,   248/248
(100 %)
3 diff
(98.8 %id)
EC530515 Prostate .a 3150 to 3250 12 to 112       101/112
(90 %)
6 diff
(94.7 %id)
AA362556   .a 3212 to 3375 1 to 164       164/164
(100 %)
0 diff
(100 %id)
AI520979 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3213 to 3379 177 to 8       170/177
(96 %)
0 diff
(100 %id)
D17156   .a 3249 to 3367 1 to 119       119/120
(99 %)
1 diff
(99.2 %id)
BM799737 eye, retinoblastoma .b 1 to 997 1 to 1009 S264L L266S L267A S268E M269H ... tiling clone,   1009/1096
(92 %)
23 diff
(98.0 %id)
BU781684 insulinoma, Pancreas .c 1 to 375 11 to 386   tiling clone,   390/386
(101 %)
8 diff
(98.0 %id)
BU786821 insulinoma, Pancreas .c 959 to 1588 645 to 16   tiling clone, AAA   630/630
(100 %)
0 diff
(100 %id)
BI858023 breast, mammary adenocarcinoma, cell line .d 1 to 735 1 to 734   tiling clone,   734/734
(100 %)
5 diff
(99.4 %id)
TI_57187775   .d 1 to 735 58 to 791       734/734
(100 %)
5 diff
(99.4 %id)
AK124414 bladder .d 361 to 2257 1 to 1894   tiling clone, available from FLJ,   1894/1894
(100 %)
2 diff
(99.9 %id)
DA041919 bladder .d 362 to 933 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DN995001 brain, whole brain .d 902 to 1555 9 to 661       653/661
(98 %)
6 diff
(99.1 %id)
BU192863 eye, retinoblastoma .d 943 to 1843 1 to 905   tiling clone,   905/906
(99 %)
10 diff
(98.9 %id)
BE086948 breast .d 1135 to 1517 7 to 388       382/395
(96 %)
4 diff
(99.0 %id)
AK022220 mammary gland .d 1177 to 3367 1 to 2190   tiling clone, available from FLJ,   2190/2190
(100 %)
5 diff
(99.8 %id)
AU121595 mammary gland .d 1178 to 2000 2 to 827   capped   826/826
(100 %)
6 diff
(99.3 %id)
DB296016 bladder .d 1723 to 2257 535 to 1       535/535
(100 %)
1 diff
(99.9 %id)
BQ371136 prostate_normal .d 1771 to 2252 486 to 5       482/486
(99 %)
0 diff
(100 %id)
AU147380 mammary gland .d 2800 to 3367 565 to 1       565/572
(98 %)
6 diff
(99.0 %id)
AA011467 liver and spleen .d 3085 to 3366 1 to 285   fully sequenced,   285/285
(100 %)
5 diff
(98.3 %id)
AA011416 liver and spleen .d 3158 to 3371 216 to 1   fully sequenced,   216/216
(100 %)
0 diff
(100 %id)
AW277238 large cell carcinoma, lung .d 3167 to 3517 1 to 351   tiling clone, Submitted on the opposite strand 351/359
(97 %)
2 diff
(99.5 %id)
CN265312 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 3336 to 3879 12 to 553       542/553
(98 %)
6 diff
(99.0 %id)
DB037247 testis .d 3373 to 3944 2 to 572   tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
DA062531 cerebellum .d 3381 to 3947 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
DB337537 testis .d 4604 to 5132 529 to 1   tiling clone,   529/529
(100 %)
0 diff
(100 %id)
CB216062 normal endometrium, late proliferativephase, cycle day 13, uterus .e 1 to 627 1 to 627 exact tiling clone,   627/627
(100 %)
0 diff
(100 %id)
BQ672900 epidermoid carcinoma, cell line, salivary gland .f 1 to 773 1 to 778 exact tiling clone,   778/845
(92 %)
7 diff
(99.2 %id)
BQ675298 epidermoid carcinoma, cell line, salivary gland .f 1 to 897 1 to 901 A3E I4L E5S R6E V7* tiling clone,   901/902
(99 %)
27 diff
(97.1 %id)
CN425717 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 1 to 420 1 to 420 G40S A63T tiling clone,   420/420
(100 %)
3 diff
(99.3 %id)
AI636269 Kidney .g 3 to 398 407 to 12   tiling clone,   396/407
(97 %)
0 diff
(100 %id)
AI675191 anaplastic oligodendroglioma, brain .g 9 to 402 411 to 18   AAA   394/394
(100 %)
6 diff
(98.5 %id)
AW195671 Kidney .g 9 to 367 360 to 1       360/360
(100 %)
4 diff
(98.9 %id)
AI262939 Kidney .g 31 to 419 392 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 389/392
(99 %)
2 diff
(99.5 %id)
BF448070 Kidney .g 62 to 366 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AW051633 Kidney .g 64 to 367 304 to 1       304/304
(100 %)
0 diff
(100 %id)
BF431328 Kidney .g 183 to 373 195 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 191/195
(97 %)
1 diff
(99.5 %id)
DN912302   .h-u 1 to 505 505 to 1 exact tiling clone,   505/505
(100 %)
0 diff
(100 %id)
DN912303   .h-u 163 to 619 1 to 456   tiling clone,   456/456
(100 %)
3 diff
(99.4 %id)
BQ354879 head_neck .i 1 to 446 1 to 447 T38N T39Q tiling clone,   447/452
(98 %)
11 diff
(97.6 %id)
AW748788 breast .j-u 1 to 351 352 to 2 exact tiling clone,   351/411
(85 %)
0 diff
(100 %id)
BE164656 head_neck .k-u 1 to 188 1 to 185 V2C F6Y P8R G9K K10N ... tiling clone,   185/194
(95 %)
6 diff
(97.0 %id)
AJ706602 bone marrow Gene AFG3L2, variant not shown         This clone was ignored    
AL046986 uterus Gene AFG3L2, variant not shown         Suspected internal deletion, this clone was ignored    
AA180116   Gene AFG3L2, variant not shown         This clone was ignored    
AA180364   Gene AFG3L2, variant not shown         This clone was ignored    
BE901919 choriocarcinoma, placenta Gene AFG3L2, variant not shown         This clone was ignored    
BG169272 hypernephroma, cell line, Kidney Gene AFG3L2, variant not shown         Suspected internal deletion    
BC024282 Skin, melanotic melanoma, high MDR. Gene AFG3L2, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BG760530 melanotic melanoma, high MDR (cell line), skin Gene AFG3L2, variant not shown       available from MGC, Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j-u, .k-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI